News & Events
Professor Sue Duval, Ph.D. of the Cardiovascular Division and Division of Biostatistics was honored at the Medical School's Wall of Scholarship induction ceremony October 25, 2018. The Wall of Scholarship recognizes faculty authors each time an individual publication reaches 1000 citations. Dr. Duval’s 2018 honor is for her paper, “A nonparametric "trim and fill" method of accounting for publication bias in meta‐analysis,” published in the Journal of the American Statistical Association in 2000. This will be Dr.
Chetan Shenoy, MD, has been named a winner of the ASCI's 2018 Young Physician-Scientist Award. Dr. Shenoy’s was among 117 nominations submitted for the 2018 Award and reviewed by the ASCI Meeting Committee. From these, 35 nominees were selected on the basis of accomplishments to date and the quality of proposed abstracts.
Dr. Shenoy will receive a $500 honorarium at the AAP/ASCI/APSA Joint Meeting, and will present his work at the ASCI's Food & Science Evening on April 21, 2018. He will also be a guest at the ASCI President's Reception and the ASCI Dinner on April 20.
Lin Yee Chen, MD, MS has just been awarded a new R01 grant from the National Heart, Lung, and Blood Institute, "Left Atrial Abnormality and Atrial Fibrillation-Related Cerebral Infarcts and Cognitive Decline" (R01HL141288, 2018-2022). The overarching goal of this project is to clarify whether it is AF per se, or the underlying left atrial abnormality, that is the principal driver of outcomes that are currently attributable to AF.
Tania Incitti, Ph.D., Post-Doctoral Associate in the lab of Rita Perlingeiro, was awarded first place among post-doctoral scholars in the Young Investigators Competition held during the Visscher Symposium on June 6, 2017. The title of her abstract was "Genomic profiling reveals novel PAX7 targets CD54, integrin α9β1 and SDC2, as markers for isolation of human ES/iPS cell-derived muscle progenitors." Tania has been a member of the Perlingeiro lab since January, 2016.
LHI researcher Rita Perlingeiro, Ph.D. has dicovered a potential life-saving treatment for acute myeloid leukemia (AML) using a designed antibody to block the activity of endoglin in the cancer cells.
The calendar below lists LHI events. The default view is all events, but you can use the links at the right to view only the LHI Lecture Series or only non-LHI lecture events.